 |
[Apha Biz=(Chicago) Reporter Paul Lee] PANAGENE, a molecular diagnostic company, will change its signboard to "HLB PANAGENE" and start anew.
Following the change of the largest shareholder to HLB Group, the board of directors was newly formed with former members of HLB Group. The change came four months after the founder was dismissed from his post due to conflicts with minority shareholders.
PANAGENE said on the 3rd that all the agenda items passed the original plan at an extraordinary shareholders' meeting held earlier in the day. Accordingly, Jin Yang-gon, the new chairman of HLB Group, △ Jang In-geun, president of HLB Bio Strategic Planning Division, △ Sohn Do-kook, managing director of HLB Biostep CFO △ Shim Kyung-jae, managing director of HLB External Cooperation Team, △ Cho Yong-ho, president of HLB Life Sciences Medical Care Division, △ Park Jae-jin, director of Panajin Research Center, was appointed as the new in-house director of Panajin. In addition, Lee Jeom-soo, an advisor to law firm Yulchon, and Shin Sung-jae, a professor of microbiology at Yonsei University, were appointed outside directors, while Shin Bong-hoon, a tax accountant, were appointed full-time auditors, respectively.
After the shareholders' meeting, he held a board meeting and appointed Jang In-geun, president of the HLB Bio Strategy Planning Division, as the new representative. The company name has also changed from Panageen to HLB PANAGENE. Panagin has completely switched to the HLB Group management system.
AlphaBIZ 폴 리(hoondork1977@alphabiz.co.kr)
